<DOC>
	<DOCNO>NCT02723461</DOCNO>
	<brief_summary>Comparing continuous intravenous oxytocin infusion pulsatile administration intravenous oxytocin augmentation first stage labor .</brief_summary>
	<brief_title>Continuous Oxytocin Infusion Versus Pulsatile Intravenous Oxytocin Augmentation First Stage Labor</brief_title>
	<detailed_description>The study population comprises120 case spontaneous onset labor admit labor ward causality Ain sham university maternity hospital . The required sample size calculate use IBM© SamplePower© Software ( IBM© Corp. , Armonk , NY , USA ) . A previous study Tribe et al. , 2012 report mean infusion delivery time associate continuous infusion oxytocin 7.17 hour 95 % confidence interval ( 95 % CI ) 6.58 7.77 hour versus 9.61 hour ( 95 % CI , 8.95 10.27 hour ) association pulsatile oxytocin . The sample size either regimen study 240 patient 241 patient , respectively . From study Tribe et al . ( 2012 ) , could estimate standard deviation ( SD ) infusion delivery time 4.66 hour 5.23 hour continuous pulsatile oxytocin regimen , respectively . This calculation derive solve follow equation SD give mean , low upper 95 % CI limit , sample size : Lower 95 % CI limit = mean - ( 1.96 * SD / √n ) ... .. Equation 1 Upper 95 % CI limit = mean + ( 1.96 * SD / √n…..Equation 2 SD standard deviation n sample size ( Chow et al. , 2003 ) . So , estimated sample size 66 patient either study group ( total , 132 patient ) would achieve power 80 % ( type II error , 0.2 ) detect statistically significant difference two group regard infusion delivery time use two-side unpaired Student test confidence level 95 % ( type I error , 0.05 ) . mean ± SD infusion delivery time group assume identical equal 9.61 ± 5.23 hour null hypothesis . Under alternative hypothesis , mean ± SD infusion delivery time assume equal 7.17 ± 4.66 hour continuous infusion group versus 9.61 ± 5.23 hour pulsatile group . This sample size 66 patient study group would power 93 % ( type II error , 0.07 ) detect statistically significant difference two group regard rate successful induction labor medium effect size ( w ) 0.3 use two-sided chi-squared test confidence level 95 % ( type I error , 0.05 ) . The effect size ( w ) calculate follow : w =√ ( χ^2/N ) , χ2 chi-squared statistic N total sample size . ( Chow et al. , 2003 ) . Following admission , patient undergo complete clinical examination detail medical history obtain follow : A . Personal history . B. Obstetric history : gestational age calculate date last menstrual period ultrasonography unreliable date . C. Gynecological history . Grouping : The patient need augmentation first stage labor divide equally two group : Group 1 ( study group ; 60 patient ) : Patients labor give augmentation oxytocin pulsatile method Group 2 ( control group ; 60 patient ) : Patients labor give augmentation oxytocin continuous method Intervention : Pulsatile group : Pulsatile infusion protocol use programmable syringe pump apply .The pulsatile regime , oxytocin ( Syntocinon , stock solution : 10 iU/mL ) administer 10 second every 6 minute dose ( 2 mU/pulse ) double every 30 minute uterine contraction establish ( 3-4 10 minute ) . This regime stem observation physiologic oxytocin may release pulsatile fashion every 4-6 minute ( Dawood et al.,1979 ) Continuous group : Continuous group administrate oxytocin ( Syntocinon , stock solution : 10 iU/mL ) start dose ( 2 mU/min ) continuous manner double every 30 minute uterine contraction establish ( 3-4 10minutes ) . Then patient case record form follow data record : 1 . Patient initial . 2 . Study number . 3 . Group . 4 . Parity . 5 . Gestatinal age ( first day last menstrual period - early ultrasound ) . 6 . Rupture membrane . 7 . Duration rupture membrane . 8 . Duration first stage labour . 9 . Duration second stage labour . 10 . Need instrumental delivery . 11 . Need Cesarean section . 12 . Adverse effect . 13 . Neonatal outcome . 14 . Maternal complication . 15 . Adverse effect relate oxytocin . 16 . Total dose oxytocin infuse . 17 . Previous complicate vaginal delivery .</detailed_description>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Inclusion Criteria 1 . Women labor ( cervical dilatation 34 centimeter ) require augmentation first stage labor . 2 . Single viable fetus . 3 . Rupture membranes augmentation labor . 4 . Cephalic presentation . 5 . Term pregnancy . 1 . Malpresentation . 2 . Induction labor prostaglandin . 3 . Any uterine previous surgery . 4 . Fetal anomaly . 5 . Premature labor . 6 . Previous cesarean section . 7 . Any uterine anomaly . 8 . Multiple pregnancy .</criteria>
	<gender>Female</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>